Brief: Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
05/06/2026 12:11
BRIEF-Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) June 5 (Reuters) - Ocular Therapeutix Inc OCUL.O:
OCULAR THERAPEUTIX™ REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Source text: ID:nGNX1qTThT
Further company coverage: OCUL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ocular Therapeutix
See all newsNASDAQ TRADE HALT HALT NEWS PENDING AT 08:40 AM
Brief: Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
EyePoint's late-stage eye drug trials to continue after safety panel review (updated)
EyePoint's late-stage eye drug trials to continue after safety panel review
Brief: Ocular Therapeutix reports inducement grants under Nasdaq listing rule 5635(C)(4)